ELST yields 3960.40% · JNJ yields 2.13%● Live data
📍 ELST pulled ahead of the other in Year 1
Combined, ELST + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ELST + JNJ for your $10,000?
Electronic Systems Technology, Inc., doing business as ESTeem Wireless Modems, designs, develops, manufactures, and markets industrial wireless products and accessories in the United States and internationally. The company's ESTeem industrial wireless products provide communication links between computer networks, network enabled devices, and mobile devices without cables. It also offers data radio products for process automation in commercial, industrial, and government arenas, as well as various accessories, such as antennas, power supplies, and cable assemblies. In addition, the company provides repair and upgrade services; and professional services, such as site survey testing, system start-up, and custom engineering. Its products are used in various applications, including water/wastewater, oil/gas, mining, and industrial automation. The company markets its products through direct sales, sales representatives, resellers, and system integrators. Electronic Systems Technology, Inc. was founded in 1982 and is based in Kennewick, Washington.
Full ELST Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.